San Diego, CA, United States of America

E Magda Barbu


 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: E Magda Barbu: Innovator in Viral Genome Engineering

Introduction

E Magda Barbu is a prominent inventor based in San Diego, CA, known for her significant contributions to the field of viral genome engineering. With a total of four patents to her name, she has made remarkable strides in the development of methods for in vitro engineering of nucleic acids.

Latest Patents

Her latest patents focus on compositions and methods for in vitro viral genome engineering. The disclosures relate to a method of in vitro engineering of nucleic acids, specifically targeting the improvement of viral properties through genomic engineering. This includes in vitro viral genomic digestion using RNA-guided Cas9, the assembly of a recombinant genome by inserting a DNA or RNA fragment into the digested viral genome, and the transformation of a host cell with the recombinant genome. Additionally, her work addresses in vitro engineering for error correction of nucleic acids.

Career Highlights

Throughout her career, E Magda Barbu has worked with various organizations, including C3J Therapeutics, Inc. Her innovative approaches have positioned her as a key figure in the biotechnology sector, particularly in the realm of viral research.

Collaborations

E Magda Barbu has collaborated with notable professionals in her field, including Kyle C Cady and Christen G DiPetrillo, who is also a woman. These collaborations have further enhanced her research and development efforts.

Conclusion

E Magda Barbu's work in viral genome engineering exemplifies the innovative spirit of modern science. Her contributions continue to pave the way for advancements in biotechnology and genetic research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…